145 related articles for article (PubMed ID: 8988054)
21. Expression of transforming growth factor beta1 gene, basic fibroblast growth factor gene and hydroxyproline in diabetes-induced bladder dysfunction in a rat model.
Yongzhi L; Benkang S; Jianping Z; Lingxia R; Wei B; Yaofeng Z; Keqin Z; Laudon V
Neurourol Urodyn; 2008; 27(3):254-9. PubMed ID: 17763394
[TBL] [Abstract][Full Text] [Related]
22. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
24. [The significance of platelet-derived endothelial cell growth factor mRNA expression in superficial bladder cancer].
Li G; Zhang YF; Ding Q; Yan CY; Wen DG
Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(8):478-81. PubMed ID: 15144643
[TBL] [Abstract][Full Text] [Related]
25. Are TGF-beta1 and bFGF correlated with bladder underactivity induced by bladder outlet obstruction?
Zhu Y; Shi B; Xu Z; Liu Y; Zhang K; Li Y; Wang H
Urol Int; 2008; 81(2):222-7. PubMed ID: 18758225
[TBL] [Abstract][Full Text] [Related]
26. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
27. Expression of hepatocyte growth factor and basic fibroblast growth factor as prognostic indicators in gastric cancer.
Zhang W; Chu YQ; Ye ZY; Zhao ZS; Tao HQ
Anat Rec (Hoboken); 2009 Aug; 292(8):1114-21. PubMed ID: 19533745
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic molecule expression is downregulated in effusions from breast cancer patients.
Konstantinovsky S; Nielsen S; Vyberg M; Kvalheim G; Nesland JM; Reich R; Davidson B
Breast Cancer Res Treat; 2005 Nov; 94(1):71-80. PubMed ID: 16142438
[TBL] [Abstract][Full Text] [Related]
29. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
[TBL] [Abstract][Full Text] [Related]
30. [Expression of cyclooxygenase-2 in human transitional cell bladder carcinomas].
Zhan J; Tang XD
Ai Zheng; 2002 Nov; 21(11):1212-6. PubMed ID: 12526218
[TBL] [Abstract][Full Text] [Related]
31. Expression of angiogenesis inhibitors in human bladder cancer may explain rapid metastatic progression after radical cystectomy.
Beecken WD; Engl T; Jonas D; Blaheta RA
Int J Mol Med; 2009 Feb; 23(2):261-6. PubMed ID: 19148551
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer.
Inoue K; Slaton JW; Kim SJ; Perrotte P; Eve BY; Bar-Eli M; Radinsky R; Dinney CP
Cancer Res; 2000 Apr; 60(8):2290-9. PubMed ID: 10786697
[TBL] [Abstract][Full Text] [Related]
33. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
[TBL] [Abstract][Full Text] [Related]
34. Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma.
Visscher DW; DeMattia F; Ottosen S; Sarkar FH; Crissman JD
Mod Pathol; 1995 Aug; 8(6):665-70. PubMed ID: 8532703
[TBL] [Abstract][Full Text] [Related]
35. [Expression of pituitary tumor-transforming gene in endometrial carcinoma].
Wang YK; Cui N; Li J; Luo B
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):538-42. PubMed ID: 15363353
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy.
Inoue K; Slaton JW; Karashima T; Yoshikawa C; Shuin T; Sweeney P; Millikan R; Dinney CP
Clin Cancer Res; 2000 Dec; 6(12):4866-73. PubMed ID: 11156246
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
[TBL] [Abstract][Full Text] [Related]
38. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
[TBL] [Abstract][Full Text] [Related]
39. Expression of interleukin-8 gene in radical prostatectomy specimens is associated with advanced pathologic stage.
Uehara H; Troncoso P; Johnston D; Bucana CD; Dinney C; Dong Z; Fidler IJ; Pettaway CA
Prostate; 2005 Jun; 64(1):40-9. PubMed ID: 15651067
[TBL] [Abstract][Full Text] [Related]
40. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
